CONCERT PHARMACEUTICALS, INC. Annual Earnings Per Share, Diluted in USD/shares from 2013 to 2021

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2013 to 2021.
  • Concert Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2022 was -0.58 USD/shares, a 25.6% increase year-over-year.
  • Concert Pharmaceuticals, Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2022 was -3.24 USD/shares.
  • Concert Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2021 was -2.33 USD/shares, a 2.92% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2020 was -2.4 USD/shares.
  • Concert Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2018 was -2.4 USD/shares, a 159% decline from 2017.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$2 +$0.07 +2.92% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 -$2 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2018 -$2 -$6 -159% Jan 1, 2018 Dec 31, 2018 10-K 2019-02-28
2017 $4.06 +$6.34 Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$2 -$3 -309% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.09 +$3.09 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$2 +$2.99 +59.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$5 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.